⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MIRA News
MIRA Pharmaceuticals, Inc. Common Stock
Cycle Syncing® Method is Clinically Shown to Reduce PMS Symptoms for 92% of participants in 60 days
prnewswire.com
MIRA
HI
MIRA Pharmaceuticals Completes Phase 1 Dosing of Ketamir-2
accessnewswire.com
MIRA
Form 8-K
sec.gov
MIRA
Yılın Müslüman Dostu Oteli-The Mira Hong Kong, Miramar Travel ve Türkiye Konsolosluğu ile İkinci Yılında Kültürel Açıdan Zenginleştirici İftar Yemeğine Ev Sahipliği Yapıyor USA - Turkish USA - English
prnewswire.com
MIRA
Women's Health Company Mira Calls for Federal Reform of U.S. Sex Education
prnewswire.com
MIRA
MIRA Pharmaceuticals Initiates Final Cohort of Ketamir-2 Phase 1 Clinical Study as Company Prepares for Phase 2a Study
accessnewswire.com
MIRA
Barjeel Geojit launches India Opportunities Fund
prnewswire.com
GFF
MIRA
MIRA Pharmaceuticals Initiates Multiple Ascending Dose (MAD) Phase 1 Study of Oral Ketamir-2 and Selects Chemotherapy-Induced Neuropathic Pain as Lead Phase 2a Indication
accessnewswire.com
MIRA
MIRA
MIRA Pharmaceuticals Announces Oral Mira-55 Outperformed Injected Morphine in Normalizing Pain and Reducing Inflammation, Supporting Its Planned IND for Chronic Inflammatory Pain
accessnewswire.com
MIRA
MIRA
MIRA Pharmaceuticals Closes Acquisition of SKNY Pharmaceuticals, Expands Pipeline with SKNY-1 for Obesity and Nicotine Addiction
accessnewswire.com
MIRA
MIRA